Xpress Biologics

Avenue De L'Hôpital 11, Giga+3
4000 Luik
BE
Xpress Biologics
Foundation date
14/04/2014
Sector
#Biotechnology / R&D ServicesSubsector
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Congenital malformations - deformations and chromosomal abnormalities
- #Digestive system
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the ear
- #Diseases of the eye
- #Diseases of the nervous system
- #Endocrine - nutritional and metabolic diseases
- #External causes of morbidity and mortality
- #Genitourinary system
- #Infectious and parasitic diseases
- #Injury - poisoning and certain other consequences of external causes
- #Mental and behavioural disorders
- #Musculoskeletal system and connective tissue
- #Neoplasms / cancer / oncology
- #Pregnancy - childbirth and the puerperium
- #Respiratory system
- #Skin and subcutaneous tissue
- #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified
Xpress Biologics is a contract development organization specialized in the production of Biologics, proteins and DNA, for preclinical applications specific to the therapeutic and diagnostic markets.Its mission is to enable the transition of the projects from R&D to clinical manufacturing.The production scale and the quality of the biologics (R&D and GLP grade material) are adapted for in vitro and in vivo pre-clinical validation of the biologics.
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2405 '22
PrecisionMed Expo & Summit
Event by: Smart Planet Media International -
2405 '22
EMERGE GHI
Event by: Smart Planet Media International
Latest news
More news-
Latest field trials validate strength of Biotalys’ first biocontrol Evoca
Thursday May 19th 2022
Read more
-
Belgian biotech in European Top-3 despite turbulent times
Wednesday May 18th 2022
Read more
-
KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus
Wednesday May 18th 2022
Read more